Wearable Injectors Market is projected to reach USD 18.87 Billion by 2032, at a CAGR of 10.0% from 2024 to 2032 | Polaris Market Research

According to the latest market research report published by Polaris Market Research, 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐖𝐞𝐚𝐫𝐚𝐛𝐥𝐞 𝐈𝐧𝐣𝐞𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟏𝟎.𝟎% 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐. With healthcare systems prioritizing decentralized care models to reduce costs and alleviate the burden on healthcare facilities, the market for wearable injectors is projected to develop over the forecast period.

A wearable injector is an innovative device that enables patients to administer medications by themselves. Using wearable injectors, patients can perform both subcutaneous administration and intravenous administration of drugs. These injectors are designed to be worn on the body, providing a hassle-free and discreet way to deliver medications.

𝑭𝒐𝒓 𝒎𝒐𝒓𝒆 𝒊𝒏𝒔𝒊𝒈𝒉𝒕𝒔 𝒊𝒏𝒕𝒐 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕, 𝒓𝒆𝒒𝒖𝒆𝒔𝒕 𝒂 𝒔𝒂𝒎𝒑𝒍𝒆 𝒐𝒇 𝒕𝒉𝒊𝒔 𝒓𝒆𝒑𝒐𝒓𝒕: https://www.polarismarketresearch.com/industry-analysis/wearable-injectors-market

Wearable injectors come in several forms, including pens, patches, and smart devices. Each of these injector types is designed to meet the specific needs of patients. Wearable injectors are an appealing choice for patients experiencing chronic conditions like diabetes and cardiovascular diseases, as they often need frequent medication administration.

𝐓𝐡𝐞 𝐰𝐞𝐚𝐫𝐚𝐛𝐥𝐞 𝐢𝐧𝐣𝐞𝐜𝐭𝐨𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟖.𝟎𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏𝟖.𝟖𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟎.𝟎% 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

Over the past few years, the prevalence of chronic conditions such as diabetes and cardiovascular diseases has increased worldwide. Wearable injectors reduce hospital visits and improve treatment adherence by allowing self-administration of medications. This, in turn, spurs the market demand for wearable injectors. Besides, the growing aging population is expected to further drive the market growth.

𝙆𝙚𝙮 𝙄𝙣𝙙𝙪𝙨𝙩𝙧𝙮 𝙋𝙖𝙧𝙩𝙞𝙘𝙞𝙥𝙖𝙣𝙩𝙨:
• Amgen Inc.
• Becton, Dickinson and Company
• CeQur SA
• Debiotech SA
• Elcam Medical
• Enable Injections
• Insulet Corporation
• Medtronic plc
• Roche Diagnostics International Ltd.
• Sorrel Medical
• Tandem Diabetes Care, Inc.
• Unilife Corporation
• United Therapeutics Corporation
• West Pharmaceutical Services, Inc.
• Ypsomed Holding AG

𝑭𝒓𝒐𝒎 𝑫𝒂𝒕𝒂 𝒕𝒐 𝑾𝒊𝒔𝒅𝒐𝒎: 𝑻𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎 𝒀𝒐𝒖𝒓 𝑨𝒑𝒑𝒓𝒐𝒂𝒄𝒉 - 𝑩𝒖𝒚 𝒀𝒐𝒖𝒓 𝑪𝒐𝒎𝒑𝒍𝒆𝒕𝒆 𝑹𝒆𝒑𝒐𝒓𝒕 𝑻𝒐𝒅𝒂𝒚. https://www.polarismarketresearch.com/buy/3810/2

𝙎𝙚𝙜𝙢𝙚𝙣𝙩𝙖𝙡 𝘼𝙣𝙖𝙡𝙮𝙨𝙞𝙨
• The market for wearable injectors is primarily segmented by type, technology, indication, end-use, and region.

• By type analysis, the on-body segment held a significant revenue share owing to its enhanced convenience and ease of use.

• By technology analysis, the spring-based segment held significant revenue share as it ensures precise and consistent drug delivery.

𝙋𝙤𝙡𝙖𝙧𝙞𝙨 𝙈𝙖𝙧𝙠𝙚𝙩 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙝𝙖𝙨 𝙨𝙚𝙜𝙢𝙚𝙣𝙩𝙚𝙙 𝙩𝙝𝙚 𝙒𝙚𝙖𝙧𝙖𝙗𝙡𝙚 𝙄𝙣𝙟𝙚𝙘𝙩𝙤𝙧𝙨 𝙢𝙖𝙧𝙠𝙚𝙩 𝙧𝙚𝙥𝙤𝙧𝙩 𝙗𝙖𝙨𝙚𝙙 𝙤𝙣 𝙩𝙮𝙥𝙚, 𝙩𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮, 𝙞𝙣𝙙𝙞𝙘𝙖𝙩𝙞𝙤𝙣, 𝙚𝙣𝙙 𝙪𝙨𝙚, 𝙖𝙣𝙙 𝙧𝙚𝙜𝙞𝙤𝙣:

Wearable Injectors, Type Outlook (Revenue - USD Billion, 2019 - 2032)
• Off-body
• On-body

Wearable Injectors, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
• Rotary pump
• Spring-based
• Expanding battery
• Motor-driven
• Others

Wearable Injectors, Indication Outlook (Revenue - USD Billion, 2019 - 2032)
• Cardiovascular Diseases
• Oncology
• Immunodeficiency
• Infectious Diseases
• Autoimmune Diseases
• Others

Wearable Injectors, End Use Outlook (Revenue - USD Billion, 2019 - 2032)
• Hospitals and Clinics
• Home Care
• Others

𝑪𝒍𝒊𝒄𝒌 𝒉𝒆𝒓𝒆 𝒕𝒐 𝑨𝒄𝒄𝒆𝒔𝒔 𝒕𝒉𝒆 𝑭𝒖𝒍𝒍 𝑹𝒆𝒑𝒐𝒓𝒕: https://www.polarismarketresearch.com/industry-analysis/wearable-injectors-market

Wearable Injectors, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
• North America
o U.S.
o Canada
• Europe
o France
o Germany
o UK
o Italy
o Netherlands
o Spain
o Russia
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Malaysia
o Indonesia
o South Korea
o Australia
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America

• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of Middle East & Africa

𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝑾𝒊𝒅𝒆-𝒓𝒂𝒏𝒈𝒊𝒏𝒈 𝑪𝒐𝒗𝒆𝒓𝒂𝒈𝒆 𝒐𝒇 𝑷𝑴𝑹'𝒔 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆 𝑳𝒂𝒏𝒅𝒔𝒄𝒂𝒑𝒆:

𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐎𝐛𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐯𝐞 𝐏𝐮𝐥𝐦𝐨𝐧𝐚𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3456149/chronic-obstructive-pulmonary-disease-market-is-expected

𝐗𝐞𝐫𝐨𝐬𝐭𝐨𝐦𝐢𝐚 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3458114/xerostomia-therapeutics-market-is-expected-to-reach-us-2-94

𝐂𝐚𝐫 𝐓 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3458611/car-t-cell-therapy-market-is-set-to-hit-us-118-680-68-million

𝐂𝐢𝐫𝐜𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐓𝐮𝐦𝐨𝐫 𝐂𝐞𝐥𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3458749/circulating-tumor-cells-market-to-receive-overwhelming-hike

𝐀𝐧𝐢𝐦𝐚𝐥 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3458803/animal-vaccines-market-is-expected-to-grow-to-us-31-07-billion

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.